我要投票 怡成在血糖仪行业中的票数:113
· 外 推 电 报 ·
2025-02-23 19:37:27 星期日

【怡成是哪个国家的品牌?】 品牌官网

怡成是什么牌子?「怡成」是 北京怡成生物电子技术股份有限公司 旗下著名品牌。该品牌发源于北京,由创始人何伟在1993-03-27期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力怡成品牌出海!通过在本页面挂载怡成品牌的产品链接和联系邮箱,可以提高怡成产品曝光!跨境电商爆单神器,目前只要100元/年哦~

北京怡成生物电子技术有限公司成立于1993年,是国内首家血糖仪生产厂家、是国家高新技术企业、中关村高新技术企业、国家高科技计划(“863”计划)支持企业、中国医疗快速检测领域的专业厂家。产品研发涉及电化学生物传感器技术、金标免疫层析技术、生物芯片技术、生化分析试剂盒、抗体试剂等多个领域。

北京怡成公司公司自成立以来一直致力于依靠持续的技术发展为社会各界提供多样的、先进的快速检测产品,不断满足人类对健康的追求。

1995年北京怡成公司推出了中国第一款家用快速血糖仪;

2004年北京怡成公司承担了国家“863”课题“便携式全血分析微系统实用化研究”;

2004年11月推出虹吸技术的“怡成超越”血糖测试仪;

2004年12月国内首次推出具有领先水平的肾损伤快速检测卡;

2005年8月获得快速乳酸检测仪新产品证书;

2006年4月推出了具有国际先进水平的5秒血糖测试仪;

2006年10月获得快速全血酮体检测仪新产品证书;

2006年11月通过ISO13458和ISO9001国际体系质量认证;

2006年12月再次承担国家“863”课题“糖化血红蛋白微芯片系统的研究”;

2008年荣获中国医疗健康产业最具成长企业证书;

2009年10月北京怡成公司总经理荣获“共和国60年共成长中华儿女商界英杰”称号;

2009年12月北京怡成公司血糖检测产品和血酮体检测产品获得欧盟CE认证;

2010年3月北京怡成公司被评为中关村百家电子城科技园高新技术企业“保增长先进单位”,并且获得政府奖励;

2010年4月北京怡成公司完成7000万元人民币的私募融资;

2010年6月“怡成”商标被评为北京市著名商标。

2010年8月怡成血糖仪被评为中国家用医疗器械顾客满意十大品牌之一;

2010年12月怡成公司评为2010年高科技、高成长亚太区500强;

2011年4月怡成公司被评为全国售后服务行业十佳单位;

2011年4月怡成快速全血酮体测试系统荣获北京市科学技术三等奖;

北京怡成公司以强大的资金实力和技术实力,围绕糖尿病和糖尿病并发症领域,不断发展着各类先进技术和实用产品,以独立自主的模式和执着创新的精神开创了国产快速血糖仪的发展道路,推动着国产血糖仪的快速普及。

北京怡成生物电子技术有限公司在经营活动中始终坚持诚信和正直,致力于为客户创造最大的价值。努力开拓新的技术和产品,在专业领域始终保持在世界领先水平,“以多彩生活,多彩怡成”为理念,积极为人类的健康事业做出贡献!

北京怡成生物电子技术有限公司作为今天社会的一员,始终以患者的需求为己任,以造福人类健康为使命,以回报社会、服务社会为光荣。

“尊重生命,热爱生活”这是企业的宗旨。

“健康是手段,快乐是目标”这是企业的行动指南。

多彩的生活,造就了多彩的怡成。

感谢生活,感谢社会。

英文翻译:Beijing Yicheng bioelectronics Technology Co., Ltd., founded in 1993, is the first manufacturer of blood glucose meter in China, a national high-tech enterprise, Zhongguancun high-tech enterprise, a national high-tech plan (863 plan) support enterprise, and a professional manufacturer in the field of rapid medical testing in China. The product research and development involves many fields such as electrochemical biosensor technology, gold standard immunochromatography technology, biochip technology, biochemical analysis kit, antibody reagent, etc. Since its establishment, Beijing Yicheng company has been committed to relying on the continuous technological development to provide the community with a variety of advanced rapid detection products, and constantly meet the human pursuit of health. In 1995, Beijing Yicheng company launched the first domestic fast blood glucose meter in China; in 2004, Beijing Yicheng company undertook the national "863" project "practical research of portable whole blood analysis microsystem"; in November 2004, it launched the "Yicheng beyond" blood glucose tester of siphon technology; in December 2004, it launched the first leading fast detection card of kidney injury in China; in August 2005, it obtained the fast New product certificate of rapid lactate tester; 5-second blood glucose tester with international advanced level was launched in April 2006; new product certificate of rapid whole blood ketone tester was obtained in October 2006; iso13458 and ISO9001 international system quality certification were passed in November 2006; national "863" project "Research on glycosylated hemoglobin microchip system" was undertaken again in December 2006; Chinese medicine was awarded in 2008 In October 2009, the general manager of Beijing Yicheng company was awarded the title of "60 years of growth of the people's Republic of China's business heroes"; in December 2009, the blood glucose test products and blood ketone test products of Beijing Yicheng company were awarded the EU CE certification; in March 2010, Beijing Yicheng company was rated as one of the top 100 high-tech enterprises in Zhongguancun Electronic City Science and Technology Park In April 2010, Beijing Yicheng company completed a private financing of 70 million yuan. In June 2010, "Yicheng" trademark was rated as a famous trademark in Beijing. In August 2010, Yicheng blood glucose meter was rated as one of the top ten brands for customer satisfaction of domestic medical devices in China; in December 2010, Yicheng company was rated as the top 500 high tech and high growth Asia Pacific region in 2010; in April 2011, Yicheng company was rated as the top 10 after-sales service industry units in China; in April 2011, Yicheng fast whole blood ketone test system won the third prize of Beijing Science and technology; and Beijing Yicheng company was rated as the top 500 high growth Asia Pacific region in 2010 With great financial strength and technical strength, around the field of diabetes and diabetic complications, we are constantly developing all kinds of advanced technologies and practical products. With independent mode and the spirit of persistent innovation, we have created the development path of domestic fast blood glucose meter and promoted the rapid popularization of domestic blood glucose meter. Beijing Yicheng bioelectronics Technology Co., Ltd. always adheres to integrity and integrity in its business activities, and is committed to creating the maximum value for customers. Strive to develop new technologies and products, and always maintain the world leading level in the professional field, "colorful life, colorful Yicheng" as the concept, and actively contribute to the cause of human health! As a member of today's society, Beijing Yicheng bioelectronics Technology Co., Ltd. always takes the needs of patients as its own responsibility, benefits human health as its mission, and rewards society and serves society as its glory. "Respect life, love life" is the purpose of the enterprise. "Health is the means, happiness is the goal" this is the enterprise's action guide. Colorful life makes a colorful happy life. Thank life, thank society.

本文链接: https://www.waitui.com/brand/c7d0b698e.html 联系电话:请联系客服添加

千城特选小程序码

7×24h 快讯

天岳先进:2024年净利润1.8亿元 同比扭亏为盈

36氪获悉,天岳先进发布业绩快报,公司2024年实现营业收入17.68亿元,同比增长41.37%;实现归属于母公司所有者的净利润1.80亿元,同比扭亏为盈。主要原因是公司大尺寸、导电型产品产能产量持续提升,销售量增加,同时产品毛利率上升。

2小时前

小米集团卢伟冰:小米15 Ultra会是越级式的一代产品

36氪获悉,小米集团合伙人兼总裁、手机部总裁、小米品牌总经理卢伟冰发文称,小米手机未来5年高端化的目标之一,就是要在6000元+价格段实现规模化的突破,“Ultra是6K+突破的关键产品,而小米15 Ultra会是越级式的一代产品”。

2小时前

恒瑞医药:羟乙磺酸达尔西利片联合内分泌治疗乳腺癌III期临床试验达主要终点

36氪获悉,恒瑞医药公告称,公司自主研发的羟乙磺酸达尔西利片在激素受体(HR)阳性、人表皮生长因子受体2(HER2)阴性女性乳腺癌辅助治疗的III期临床试验中,首次期中分析主要终点达到统计学显著性。研究结果显示,达尔西利联合内分泌治疗可显著降低患者复发风险,提高患者无侵袭性疾病生存期(IDFS)。公司已向国家药品监督管理局药品审评中心递交上市前沟通交流申请。该药品是公司自主研发的化学药品1类新药,是一种口服、高效、选择性的小分子CDK4/6抑制剂。

2小时前

深圳:近期将发布人形机器人专项政策 在全市科技重大专项中安排人工智能和机器人专项

深圳市政府新闻办2月23日召开“打造最好科技创新生态和人才发展环境”主题新闻发布会。市人工智能产业办主任林毅在会上表示,深圳在人工智能和机器人领域基础雄厚、未来可期。下一步,我们将在政策、场景、创新、机器人四个方面持续发力。此外,近期我们还将发布人形机器人专项政策,通过“揭榜挂帅”等方式,对开放应用场景、突破关键技术、构建专用数据集、提升规模化制造和应用能力等予以精准支持。同时,还将在全市科技重大专项中安排人工智能和机器人专项,鼓励产、学、研、用组成创新联合体进行协同攻关。(财联社)

2小时前

一汽大众ID.系列部分车型官降至高5.5万元

一汽-大众宣布对旗下ID.系列部分车型进行降价,最高降幅达5.5万元。此次降价活动涉及ID.4 CROZZ和ID.6 CROZZ两款车型,无门槛一口价分别为13.99万元和19.59万元起,还可叠加官方置换补贴至高1万元、国家置换补贴至高2万元。(财联社)

2小时前

本页详细列出关于万孚Wondfo的品牌信息,含品牌所属公司介绍,万孚Wondfo所处行业的品牌地位及优势。
咨询